Alkermes reports positive data on multiple sclerosis drug

A board to discuss future MS therapies in early stage (Phase I or II) trials.

Alkermes reports positive data on multiple sclerosis drug

Postby MSUK » Wed Feb 11, 2015 6:07 am

Alkermes reports positive data on multiple sclerosis drug ALKS 8700

Alkermes plc has reported positive top-line data from a phase I study on its experimental MS drug, ALKS 8700. ALKS 8700 is a novel monomethyl fumarate (MMF) molecule being developed for the treatment of MS..... Read More - http://www.ms-uk.org/emergingtherapies
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2903
Joined: Wed Oct 14, 2009 3:00 pm

Advertisement

Return to Drug Pipeline

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service